Page 13 - Chinese (SSE) Pharmaceuticals & Biotech Dividend Stocks

UPDATED May 04, 2024

Discover Chinese Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the SSE and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

295 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2755

Beijing Aosaikang Pharmaceutical
CN¥11.1814.1%0.4%CN¥10.4bn/aPS6.7xn/a0%

2022

Shanghai Kehua Bio-EngineeringLtd
CN¥7.364.7%-41.1%CN¥3.8bn/aPS1.9xn/a0%

2198

Guangdong Jiaying Pharmaceutical
CN¥6.551.2%-14.9%CN¥3.3bn/aPE121.7xn/a0%

2693

Hainan Shuangcheng Pharmaceuticals
CN¥5.264.4%-20.7%CN¥2.2bn/aPS11.1xn/a0%

300267

Hunan Er-Kang Pharmaceutical
CN¥2.574.9%-24.2%CN¥5.3bn/aPS3.5xn/a0%

300313

Xinjiang Tianshan Animal Husbandry Bio-engineering
CN¥6.741.5%21.9%CN¥2.1bn/aPS16xn/a0%

603716

Thalys Medical Technology Group
CN¥7.245.7%-25.0%CN¥1.4bn/aPB1.2xn/a0%
Page 13 of 13
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.